Key driving factors in this market are aging population and chronic diseases. Aging Population: Past few decades have recorded a steeping rise in the population of aging people. Growing number of aging people is directly associated with health issues related with nerves and their activity level. Timely intervention in this activity is becoming essential. Elderly suffering from movement disorders, chronic pain, cardiovascular disorders and other age-related issues are driving the industry. Varied applications of the neurostimulation procedures have vital impact on the global market. Scope of the Report: This report focuses on the Neuromodulation Devices and Implantable Infusion Pumps in United States market. This report categorizes the market based on manufacturers, type and application. Market Segment by Manufacturers, this report covers Medtronic Boston Scientific Corporation St. Jude Medical Synapse Biomedical Nevro Corporation Neuropace Cyberonics Autonomic Technologies Avery Biomedical Greatbatch Medical Market Segment by Type, covers Spinal Cord Stimulation Deep Brain Stimulation Sacral Nerve Stimulation Vagal Nerve Stimulation Gastric Stimulation Transcranial magnetic Stimulation Transcutaneous Electrical Stimulation Other Market Segment by Applications, can be divided into Parkinson's disease Epilepsy Pain Other There are 11 Chapters to deeply display the United States Neuromodulation Devices and Implantable Infusion Pumps market. Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, with sales, revenue, and price of Neuromodulation Devices and Implantable Infusion Pumps, in 2015 and 2016; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016; Chapter 4 and 5, to show the market of Neuromodulation Devices and Implantable Infusion Pumps by type and application, with sales market share and growth rate by type, application, from 2011 to 2016; Chapter 6, Neuromodulation Devices and Implantable Infusion Pumps market forecast, by type and application, with sales and revenue, from 2016 to 2021; Chapter 7, to analyze the Neuromodulation Devices and Implantable Infusion Pumps market development potential except United States, covering China, Southeast Asia, India, Latin America etc. Chapter 8, 9, 10 and 11, to describe sales channel, distributors, traders, dealers, market effect factors, appendix and data source.
Table of Contents United States Neuromodulation Devices and Implantable Infusion Pumps Market by Manufacturers, Type and Application, Forecast to 2021 1 Market Overview (Market Segment, Status and Outlook) 1.1 Neuromodulation Devices and Implantable Infusion Pumps Introduction 1.2 United States Neuromodulation Devices and Implantable Infusion Pumps Market Analysis by Type 1.
